Level Chart

Basic Info

Eli Lilly & Co (LLY) - Oncology Revenue is at a current level of 6.658B, up from 5.666B one year ago. This is a change of 17.51% from one year ago.

Oncology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to oncology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 6.658B
Latest Period 2023
Last Updated Feb 15 2024, 08:41 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 6.80%
Value from 1 Year Ago 5.666B
Change from 1 Year Ago 17.51%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 6.658B
December 31, 2022 5.666B
December 31, 2021 5.741B
December 31, 2020 5.319B
December 31, 2019 4.614B
December 31, 2018 4.260B
Date Value
December 31, 2017 3.812B
December 31, 2016 3.722B
December 31, 2015 3.510B
December 31, 2014 3.393B
December 31, 2013 3.268B
December 31, 2012 3.282B

Basic Info

Eli Lilly & Co (LLY) - Oncology Revenue is at a current level of 6.658B, up from 5.666B one year ago. This is a change of 17.51% from one year ago.

Oncology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to oncology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 6.658B
Latest Period 2023
Last Updated Feb 15 2024, 08:41 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 6.80%
Value from 1 Year Ago 5.666B
Change from 1 Year Ago 17.51%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co -0.46%